{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T18:00:08Z","timestamp":1785261608062,"version":"3.55.0"},"reference-count":57,"publisher":"BMJ","funder":[{"name":"the Key Project of Changzhou Medical Center of Nanjing Medical University","award":["CMCM202302"],"award-info":[{"award-number":["CMCM202302"]}]},{"name":"the Prospective Research Program of Changzhou Xitaihu Development Foundation For Frontier Cell-Therapeutic Technology","award":["2022-P-017"],"award-info":[{"award-number":["2022-P-017"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273239"],"award-info":[{"award-number":["82273239"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2026,7,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The liver naturally exhibits robust glycosylation processes, yet how aberrant glycosylation affects hepatocellular carcinoma (HCC) and its underlying mechanisms remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the role of heparan sulphate (HS) modification in HCC progression and identify its underlying regulatory mechanism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>The association of HS with poor prognosis and immune dysfunction was analysed through HCC clinical data and in vivo models. T cell functions were validated in vivo and in vitro via exogenous HS or HS depletion. Transcriptomic screening of HS-high and HS-low tumour clones was performed to identify upstream regulators of HS. Candidate galectin-14 was functionally confirmed through genetic manipulation in vitro and in transgenic mice. Metabolic and protein-interaction studies showed how galectin-14 drives UDP-glycosyl donor production and HS synthesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Elevated HS modification correlated with poor survival and was linked to T cell exhaustion in patients with HCC. The primate-specific oncofetal protein galectin-14 was identified as an upstream regulator of HS synthesis. Galectin-14 promoted HCC progression and immune evasion by inducing contact-dependent CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell exhaustion, partly mediated by FGFR1 signalling on T cells. It reprogrammed glycometabolism to boost synthesis of UDP-glycosyl donors (UDP-Glc, UDP-GlcNAc, UDP-GlcA) required for HS chains. Mechanistically, galectin-14 directly bound UDP-glucose pyrophosphorylase 2 (UGP2), facilitating its oligomerisation and enzymatic activity, thereby fueling HS production.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study defines galectin-14 as a key oncofetal regulator of HCC immunosuppression by rewiring UGP2-mediated glycosyl donor production to promote elevated HS modification and T cell dysfunction, highlighting a potential diagnostic marker and promising therapeutic avenue in HCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2026-338068","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T17:20:20Z","timestamp":1785259220000},"page":"gutjnl-2026-338068","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Galectin-14, a primate-specific oncofetal protein, impairs anti-tumour immunity in hepatocellular carcinoma by driving elevated heparan sulphate modification"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1082-9319","authenticated-orcid":false,"given":"Gang","family":"Yang","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, National Health Commission Key Laboratory of Antibody Techniques, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0388-584X","authenticated-orcid":false,"given":"Liming","family":"Gou","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Children\u2019s Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Department of Cell Biology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5328-3427","authenticated-orcid":false,"given":"Xuebin","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, National Health Commission Key Laboratory of Antibody Techniques, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0864-8459","authenticated-orcid":false,"given":"Chi","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, National Health Commission Key Laboratory of Antibody Techniques, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5537-7709","authenticated-orcid":false,"given":"Qian","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, National Health Commission Key Laboratory of Antibody Techniques, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7251-9694","authenticated-orcid":false,"given":"Yue","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, National Health Commission Key Laboratory of Antibody Techniques, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Changzhou Medical Center, the Second People\u2019s Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Changzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9933-9505","authenticated-orcid":false,"given":"Dandan","family":"Zheng","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, National Health Commission Key Laboratory of Antibody Techniques, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1913-9988","authenticated-orcid":false,"given":"Ming","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, National Health Commission Key Laboratory of Antibody Techniques, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Jiangsu Animal Experimental Center of Medicine and Pharmacy, Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0256-3478","authenticated-orcid":false,"given":"Chunfu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Changzhou Medical Center, the Second People\u2019s Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Changzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3162-4070","authenticated-orcid":false,"given":"Yonglin","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Hepatology, Department of Infectious Diseases, The Affiliated Taizhou People\u2019s Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Nanjing Xuanwu Hospital, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0468-5393","authenticated-orcid":false,"given":"Sujuan","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, National Health Commission Key Laboratory of Antibody Techniques, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9425-4502","authenticated-orcid":false,"given":"Tong","family":"Ding","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, National Health Commission Key Laboratory of Antibody Techniques, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7560-4826","authenticated-orcid":false,"given":"Luan","family":"Sun","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, National Health Commission Key Laboratory of Antibody Techniques, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Changzhou Medical Center, the Second People\u2019s Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Changzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2713-2156","authenticated-orcid":false,"given":"Bin","family":"Xue","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Children\u2019s Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Changzhou Medical Center, the Second People\u2019s Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Changzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8488-7902","authenticated-orcid":false,"given":"Fang","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, National Health Commission Key Laboratory of Antibody Techniques, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Jiangsu Provincial Key Laboratory of Chronic Digestive Diseases, The First Affiliated Hospital with Nanjing Medical University, Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7889-1662","authenticated-orcid":false,"given":"Wei","family":"Gao","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, National Health Commission Key Laboratory of Antibody Techniques, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Personalized Cancer Medicine, Nanjing Medical University, Nanjing, Jiangsu, China"},{"name":"Changzhou Medical Center, the Second People\u2019s Hospital of Changzhou, the Third Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Changzhou, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"2026072810201363000_gutjnl-2026-338068v1.1","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-01886-1","article-title":"Glycosylation: mechanisms, biological functions and clinical implications","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2026072810201363000_gutjnl-2026-338068v1.2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/humupd\/dmad024","article-title":"The functional roles of protein glycosylation in human maternal-fetal crosstalk","volume":"30","author":"Zhong","year":"2024","journal-title":"Hum Reprod Update"},{"key":"2026072810201363000_gutjnl-2026-338068v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-020-00294-x"},{"key":"2026072810201363000_gutjnl-2026-338068v1.4","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-016-0334-6","article-title":"Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma","volume":"9","author":"Ho","year":"2016","journal-title":"J Hematol Oncol"},{"key":"2026072810201363000_gutjnl-2026-338068v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.08.025"},{"key":"2026072810201363000_gutjnl-2026-338068v1.6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jhep.2008.12.010","article-title":"Alteration of protein glycosylation in liver diseases","volume":"50","author":"Blomme","year":"2009","journal-title":"J Hepatol"},{"key":"2026072810201363000_gutjnl-2026-338068v1.7","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202312154","article-title":"Sweet but Challenging: Tackling the Complexity of GAGs with Engineered Tailor-Made Biomaterials","volume":"36","author":"Le Pennec","year":"2024","journal-title":"Adv Mater"},{"key":"2026072810201363000_gutjnl-2026-338068v1.8","doi-asserted-by":"publisher","DOI":"10.1111\/febs.17107"},{"key":"2026072810201363000_gutjnl-2026-338068v1.9","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/blood.2023022736","article-title":"Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis","volume":"143","author":"Piszczatowski","year":"2024","journal-title":"Blood"},{"key":"2026072810201363000_gutjnl-2026-338068v1.10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004952","article-title":"Heparan sulfate proteoglycans","volume":"3","author":"Sarrazin","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2026072810201363000_gutjnl-2026-338068v1.11","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02462-1"},{"key":"2026072810201363000_gutjnl-2026-338068v1.12","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001875","article-title":"Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma","volume":"9","author":"Sun","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026072810201363000_gutjnl-2026-338068v1.13","doi-asserted-by":"crossref","first-page":"26245","DOI":"10.1038\/srep26245","article-title":"Epitope mapping by a Wnt-blocking antibody: evidence of the Wnt binding domain in heparan sulfate","volume":"6","author":"Gao","year":"2016","journal-title":"Sci Rep"},{"key":"2026072810201363000_gutjnl-2026-338068v1.14","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adi7764","article-title":"Syndecan-1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy","volume":"10","author":"Liu","year":"2024","journal-title":"Sci Adv"},{"key":"2026072810201363000_gutjnl-2026-338068v1.15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-797050"},{"key":"2026072810201363000_gutjnl-2026-338068v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.07.016"},{"key":"2026072810201363000_gutjnl-2026-338068v1.17","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41423-023-01096-9","article-title":"A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells","volume":"20","author":"Mart\u00edn-Cruz","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"2026072810201363000_gutjnl-2026-338068v1.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011165"},{"key":"2026072810201363000_gutjnl-2026-338068v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.11.043"},{"key":"2026072810201363000_gutjnl-2026-338068v1.20","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat6114","article-title":"Immune responses at the maternal-fetal interface","volume":"4","author":"Ander","year":"2019","journal-title":"Sci Immunol"},{"key":"2026072810201363000_gutjnl-2026-338068v1.21","doi-asserted-by":"publisher","DOI":"10.1002\/med.21455"},{"key":"2026072810201363000_gutjnl-2026-338068v1.22","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.trecan.2018.09.004","article-title":"Glypicans as Cancer Therapeutic Targets","volume":"4","author":"Li","year":"2018","journal-title":"Trends Cancer"},{"key":"2026072810201363000_gutjnl-2026-338068v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.01.047"},{"key":"2026072810201363000_gutjnl-2026-338068v1.24","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/biolre\/ioad114","article-title":"Placental galectins: a subfamily of galectins lose the ability to bind \u03b2-galactosides with new structural features\u2020","volume":"109","author":"Pei","year":"2023","journal-title":"Biol Reprod"},{"key":"2026072810201363000_gutjnl-2026-338068v1.25","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac558","article-title":"GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels","volume":"24","author":"Liu","year":"2023","journal-title":"Brief Bioinform"},{"key":"2026072810201363000_gutjnl-2026-338068v1.26","article-title":"Electronic address wbe, Cancer Genome Atlas Research N. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma","volume":"169","year":"2017","journal-title":"Cell"},{"key":"2026072810201363000_gutjnl-2026-338068v1.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08244-9"},{"key":"2026072810201363000_gutjnl-2026-338068v1.28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adr2151","article-title":"OX40-heparan sulfate binding facilitates CAR T cell penetration into solid tumors in mice","volume":"17","author":"Zhang","year":"2025","journal-title":"Sci Transl Med"},{"key":"2026072810201363000_gutjnl-2026-338068v1.29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1088024","article-title":"Placental galectins regulate innate and adaptive immune responses in pregnancy","volume":"13","author":"Oravecz","year":"2022","journal-title":"Front Immunol"},{"key":"2026072810201363000_gutjnl-2026-338068v1.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06155-9"},{"key":"2026072810201363000_gutjnl-2026-338068v1.31","doi-asserted-by":"publisher","DOI":"10.1038\/35039551"},{"key":"2026072810201363000_gutjnl-2026-338068v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.01.005"},{"key":"2026072810201363000_gutjnl-2026-338068v1.33","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-1542"},{"key":"2026072810201363000_gutjnl-2026-338068v1.34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000505695","article-title":"Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma","volume":"9","author":"Deng","year":"2020","journal-title":"Liver Cancer"},{"key":"2026072810201363000_gutjnl-2026-338068v1.35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.7555\/JBR.37.20230085","article-title":"Galectin-14 promotes hepatocellular carcinoma tumor growth via enhancing heparan sulfate proteoglycan modification","volume":"37","author":"Gou","year":"2023","journal-title":"J Biomed Res"},{"key":"2026072810201363000_gutjnl-2026-338068v1.36","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-23-0816"},{"key":"2026072810201363000_gutjnl-2026-338068v1.37","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"2026072810201363000_gutjnl-2026-338068v1.38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0903568106"},{"key":"2026072810201363000_gutjnl-2026-338068v1.39","doi-asserted-by":"crossref","DOI":"10.1016\/j.crmeth.2023.100518","article-title":"Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation","volume":"3","author":"Sunden","year":"2023","journal-title":"Cell Rep Methods"},{"key":"2026072810201363000_gutjnl-2026-338068v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.22, 10.1038\/nrn.2017.89, 10.1038\/nrn.2017.87"},{"key":"2026072810201363000_gutjnl-2026-338068v1.41","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-05733-z","article-title":"The role of N-glycosylation modification in the pathogenesis of liver cancer","volume":"14","author":"Hu","year":"2023","journal-title":"Cell Death Dis"},{"key":"2026072810201363000_gutjnl-2026-338068v1.42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.trecan.2020.04.002","article-title":"Targeting Glycosylation: A New Road for Cancer Drug Discovery","volume":"6","author":"Costa","year":"2020","journal-title":"Trends Cancer"},{"key":"2026072810201363000_gutjnl-2026-338068v1.43","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/cac2.12610","article-title":"Altered glycosylation in cancer: molecular functions and therapeutic potential","volume":"44","author":"Xu","year":"2024","journal-title":"Cancer Commun"},{"key":"2026072810201363000_gutjnl-2026-338068v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.02.001"},{"key":"2026072810201363000_gutjnl-2026-338068v1.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.06.008"},{"key":"2026072810201363000_gutjnl-2026-338068v1.46","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abg3072","article-title":"Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies","volume":"14","author":"Greco","year":"2022","journal-title":"Sci Transl Med"},{"key":"2026072810201363000_gutjnl-2026-338068v1.47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38371-2"},{"key":"2026072810201363000_gutjnl-2026-338068v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1340-y"},{"key":"2026072810201363000_gutjnl-2026-338068v1.49","doi-asserted-by":"crossref","first-page":"103980","DOI":"10.1016\/j.jri.2023.103980","article-title":"The unique expression pattern of human leukocyte antigen in trophoblasts potentially explains the key mechanism of maternal-fetal tolerance and successful pregnancy","volume":"158","author":"Peng","year":"2023","journal-title":"J Reprod Immunol"},{"key":"2026072810201363000_gutjnl-2026-338068v1.50","doi-asserted-by":"crossref","first-page":"S176","DOI":"10.1016\/j.placenta.2010.12.014","article-title":"Review: Fetal antigens--identity, origins, and influences on the maternal immune system","volume":"32 Suppl 2","author":"Petroff","year":"2011","journal-title":"Placenta"},{"key":"2026072810201363000_gutjnl-2026-338068v1.51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01240","article-title":"Placental Galectins Are Key Players in Regulating the Maternal Adaptive Immune Response","volume":"10","author":"Balogh","year":"2019","journal-title":"Front Immunol"},{"key":"2026072810201363000_gutjnl-2026-338068v1.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2014.07.015"},{"key":"2026072810201363000_gutjnl-2026-338068v1.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2017.01.130"},{"key":"2026072810201363000_gutjnl-2026-338068v1.54","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00279","article-title":"Lactic Acid: A Novel Signaling Molecule in Early Pregnancy?","volume":"11","author":"Ma","year":"2020","journal-title":"Front Immunol"},{"key":"2026072810201363000_gutjnl-2026-338068v1.55","unstructured":"Yang G . Data from: huh-7 lgals14 knockdown. In: National Omics Data Encyclopedia (NODE), accession OEP00006387. Available: https:\/\/www.biosino.org\/node\/project\/detail\/OEP00006387 [accessed 11 Oct 2025]."},{"key":"2026072810201363000_gutjnl-2026-338068v1.56","unstructured":"Yang G . Data from: huh-7 single cell. In: National Omics Data Encyclopedia (NODE), accession OEP00006554. Available: https:\/\/www.biosino.org\/node\/project\/detail\/OEP00006554 [accessed 11 Oct 2025]."},{"key":"2026072810201363000_gutjnl-2026-338068v1.57","unstructured":"Yang G . Data from: the role of heparan sulfate in car-t mediated tumor killing. In: National Omics Data Encyclopedia (NODE), accession OEP00006486. Available: https:\/\/www.biosino.org\/node\/project\/detail\/OEP00006486 [accessed 11 Oct 2025]."}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2026-338068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T17:20:25Z","timestamp":1785259225000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2026-338068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":57,"alternative-id":["10.1136\/gutjnl-2026-338068"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2026-338068","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]}}}